Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

USP Proposes Strengthened Partnership With HHS, FDA, To Help Protect Patients and Consumers

By Pharmaceutical Processing | February 3, 2009

With the Obama administration’s renewed national focus on protecting public health, the U.S. Pharmacopeial (USP) Convention has offered its scientific expertise and a series of recommendations to Tom Daschle, secretary-designate of the Department of Health and Human Services (HHS) and Frank Torti, M.D., MPH, acting commissioner of the Food and Drug Administration (FDA). USP is a private, non-profit public health organization that sets public standards to help ensure the quality, safety and benefit of medicines and foods worldwide. Under the 1938 Food, Drug and Cosmetic Act, prescription and over-the-counter medicines sold in the United States must comply with quality standards published in USP’s book of standards, the United States Pharmacopeia. In separate letters to Mr. Daschle and Dr. Torti, Roger L. Williams, M.D., USP’s chief executive officer, outlined the areas in which USP can offer scientific support and expertise as the new administration explores ways to better secure the nation’s supplies of medicines and foods. “President Obama has made a welcome commitment to science in many areas, and reinforcing the safety nets that help ensure the quality of medicines and food ingredients must be a priority,” said Dr. Williams. “At a time when global economic pressures may increase the risk of adulteration of drugs or foods for economic gain, as seen recently with heparin, glycerin and melamine, the need for rigorous standards and practices is more urgent than ever. Consumers and patients depend on FDA to enforce USP’s standards. USP, with its internationally recognized scientific expertise, can be important resources for HHS and FDA in this shared public health mission.” Among USP’s recommendations to HHS and FDA are sufficient funding for FDA; expanded use of quality standards in drug and food quality; greater international regulatory outreach; conserving FDA resources through use of resources such as USP’s verification programs; and promoting harmonization among international bodies that set quality standards. The letters to Mr. Daschle and Dr. Torti, along with the complete list of observations and recommendations, are at www.usp.org .

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards